RAS- Targeted Drug Discovery Europe Summit

Conference themes
After three decades of trial and error to target the driver of 30% of all diagnosed cancers, scientists are finally making meaningful clinical progression to target the cancer master switch, the RAS family of proteins. The RAS- Targeted Drug Discovery Summit Europe is the only industry and translational focused platform dedicated to bringing you innovative anti-RAS drug discovery science, capturing the most pioneering data, thought-provoking insights and practical lessons learned.

Professional congress organizer (PCO)
Hanson Wade

Notes
Speakers: Julian Downward, Francis Crick Institute, Mariano Barbacid, CNIO (Spanish National Cancer Research Center), Darryl McConnell, Boehringer Ingelheim, Dwight V. Nissley and many more.

https://go.evvnt.com/533448-1?pid=4832

Ms. Shima Salmasi